Navigation Links
Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
Date:11/7/2007

n-Janssen.

About Centocor

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis.

The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders. Centocor, Inc. is a wholly owned subsidiary of Johnson & Johnson.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result
'/>"/>

SOURCE Centocor Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is scheduled ... Healthcare Conference on May 6 in Boston ... and chief financial officer, and Susie Lisa , vice ... answer session regarding the company with the host analyst at ... the presentation and question and answer session will be available ...
(Date:4/24/2015)... 2015  Novartis Pharmaceuticals Corporation (NPC) has been named the ... row on the annual DiversityInc Top 50 Companies for Diversity ... Companies for Diversity on April 23 at an awards ceremony ... ranked second on the DiversityInc Top 10 Companies for Recruitment ... Resource Groups list. David Epstein , ...
(Date:4/24/2015)... 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products and a licensed producer ("LP") ... Regulations ( Canada ) ("MMPR"), is pleased ... shareholders, has closed the transaction announced on March 11, ... (the "Escrow Transfer") a total of 20,156,790 common shares ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
... 2011 On Wednesday, April 27 at 11 a.m., ... Langevin, Governor Lincoln Chafee, Lieutenant Governor Elizabeth H. Roberts, ... at its headquarters at 211 Circuit Drive in North ... Peter F. Kilmartin will tour Dominion,s laboratory at 1 ...
... JACKSON, Wis., April 25, 2011 Wisconsin Pharmacal Company, ... market recall of Triad Povidone Iodine Prep Pads, manufactured ... names including Triad. The Triad Povidone Iodine Prep Pads ... distributed by Wisconsin Pharmacal Company. In the interest of ...
Cached Medicine Technology:Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials 2Important Information for Atwater Carey First Aid Kit Consumers Regarding Triad Group's Povidone Iodine Prep Pads 2
(Date:4/24/2015)... York, NY (PRWEB) April 24, 2015 ... sober living residence in Westchester County. Just 35 miles ... help transition individuals back into everyday life while recovering ... Thursday, May 7, 2015, will allow therapists, doctors and ... areas and learn more about the opportunities offered by ...
(Date:4/24/2015)... Foothill Ranch, California (PRWEB) April 24, 2015 ... that has a wide range of capabilities and services ... etc. , Ryadon's Quantity Discount Program will be ... ) as follows: , Order 4-19: Receive 10% discount ... Can Benefit by Using the Drawer Slides Products, ...
(Date:4/24/2015)... York (PRWEB) April 24, 2015 ... move forward in the federal multidistrict litigation underway ... According to court documents, the parties involved in ... April 16th detailing, among other things, preparation for ... that counsel for both plaintiffs and defendants have ...
(Date:4/24/2015)... The first step to transforming one’s life ... meditation and yoga teacher Stine Koppernæs, meditation and changing ... that allow her to experience more peace and freedom ... teacher since 2006, and through the years she has ... , “I love sharing this way of finding true, ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term Care ... exclusive agreement with LTC Solutions for All LLC (SFA) ... , Anchor has more than 18 years of experience ... and is currently the designated advocate for the American ... member benefit. , “I am very pleased to be ...
Breaking Medicine News(10 mins):Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... Millions of Americans have an undiagnosed artery disorder that can ... study reveals. The disorder is fibromuscular dysplasia, an accumulation ... narrow. The condition can occur in any artery but occurs ... to 4 percent of Americans. If untreated, fibromuscular dysplasia ...
... request that the journals Science and ... modified H5N1 virus because of biosecurity concerns does not ... They caution, however, that a fair, transparent process ... on disseminating scientific information., Writing in Science , ...
... are not as fit as earlier generations, and even the ... of inactivity could have a major long-term health impact. ... on a survey of Norwegian schoolchildren,s performance in the 3 ... Leif Inge Tjelta and Sindre Dyrstad at the University of ...
... , ROCHESTER, Minn. -- Results of two studies suggest ... developed in a collaboration between Mayo Clinic and Exact ... significantly more sensitive than other noninvasive tests at detecting ... important implications for clinicians and tens of thousands of ...
... of new federal legislation, electronic health records (EHRs) are ... nurses the frontline providers of care. In the ... University of Pennsylvania School of Nursing determined that nurses ... care and better health outcomes for patients than nurses ...
... investigational drug called regorafenib slowed the progression of tumors and ... , an international phase III clinical trial found. The findings ... the American Society of Clinical Oncology in San Francisco ... , principal investigator of the trial in the United States. ...
Cached Medicine News:Health News:Narrowed Artery Condition Often Goes Undiagnosed: Study 2Health News:Balancing scientific freedom and national security 2Health News:Balancing scientific freedom and national security 3Health News:Sitting it out 2Health News:Sitting it out 3Health News:New test offers greater accuracy in early detection of colorectal cancer 2Health News:New test offers greater accuracy in early detection of colorectal cancer 3Health News:Better together - The RN and the EHR 2Health News:Drug improves survival of colorectal cancer patients, trial results show 2
... Super Pulse sealed CO2 surgical lasers offer ... the experience and support services of a ... laser experience. All settings are available at ... MD Super Pulse surgical lasers are compatible ...
... and targeting make treatment quick and effective ... cone angle, adjustable offset and variable pulse ... on the most modern IOLs without damage ... optics ensure low energy plasma formation with ...
... Pentacam images the anterior segment of the ... This rotating process supplies pictures in three ... measured very precisely because of this rotational ... than two seconds and minute eye movements ...
... SP-2000P Non -Contact Specular Microscope is ... and versatility in non-contact specular microscopy. ... Topcon's Imagenet system. Dual measurement system: ... 3D auto alignment and auto capture ...
Medicine Products: